What is NUTX's health score?

Nutex Health Inc. (NUTX) has a TradeApes health score of 66 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is NUTX's estimated fair value?

Based on our 5-year discounted cash flow model, Nutex Health Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is NUTX undervalued or overvalued?

Our model currently rates NUTX as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

3 free score cards remaining

Nutex Health Inc. (NUTX)

Technology Inconclusive inconclusive healthy

$162.98

Updated: 2026-07-18

TradeApes Score

Financial Strength

90 Strong

Operating Trend

60 Healthy

Relative Value

65 Healthy

Capital Allocation

30 Weak

Risk Management

80 Strong

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− High stock comp burden — SBC 8–15% of revenue, material dilution cost

Unlock Full Report →

Industry Related Stocks

Accenture plc (ACN) ACV Auctions Inc. (ACVA) Advantage Solutions Inc. (ADV) Akso Health Group (AHG) AKAMAI TECHNOLOGIES INC (AKAM) Alight, Inc. / Delaware (ALIT)

See all Technology stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.